Dividend on the way · $0.17
Kamada
Develops plasma-derived therapies and distributes biopharmaceutical products in Israel and the MENA region.
$8.29
After-hours close+0.01 (+0.12%)
At close$8.28(+0.24%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 8.89%5.13M sharesInsiders 43.14%24.89M sharesOther 47.97%27.68M shares
Shares outstanding 57.69M · Float 31.45M · 54.5% free float
Institutions13F, as of Mar 31, 2026
43 holders · 5.13M shares · 5 new positions · 21 increased · 17 reduced · 8 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Phoenix Holdings Ltd. | 1.65M | 2.87% | 0 | May 11, 2026 |
| Renaissance Technologies LLC | 762.9K | 1.32% | −76.4K | May 14, 2026 |
| Wells Fargo & Company/MN | 597.2K | 1.04% | −6.4K | Jul 8, 2026 |
| Acadian Asset Management LLC | 371.6K | 0.64% | +57.5K | May 13, 2026 |
| Ark Investment Management LLC | 269.6K | 0.47% | +269.6K | May 12, 2026 |
| Two Sigma Investments, LP | 194.2K | 0.34% | +53.6K | May 15, 2026 |
| Envestnet Asset Management Inc | 166.1K | 0.29% | +156.0K | May 4, 2026 |
| Huntleigh Advisors, Inc. | 155.5K | 0.27% | +6.1K | Apr 21, 2026 |
Beneficial owners13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Ishay Davidi | director, 10 percent owner: | 22.08M | 38.28% | Mar 23, 2026 |
| Leon Recanati | director | 2.09M | 3.62% | Mar 16, 2026 |
| David Tsur | director | 607.9K | 1.05% | Mar 16, 2026 |
| Amir London | officer: Chief Executive Officer | 61.9K | 0.11% | Mar 16, 2026 |
| Orit Pinchuk | officer: VP Regulatory Affairs | 12.1K | 0.02% | Mar 16, 2026 |
| Chaime Orlev | officer: Chief Financial Officer | 11.6K | 0.02% | Mar 16, 2026 |
| Eran Nir | officer: Vice President, Operations | 10.4K | 0.02% | Mar 16, 2026 |
| Yael Brenner | officer: VP Quality | 6.3K | 0.01% | Mar 16, 2026 |
| Shavit Beladev | officer: VP Plasma Operations | 3.4K | 0.01% | Mar 16, 2026 |
| Hanni Neheman | officer: VP, Marketing & Sales | 3.4K | 0.01% | Mar 16, 2026 |
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.